HMG-CoA reductase inhibitor rosuvastatin improves abnormal brain electrical activity via mechanisms involving eNOS. [electronic resource]
Producer: 20151222Description: 349-359 p. digitalISSN:- 1873-7544
- Animals
- Anticonvulsants -- pharmacology
- Atorvastatin -- pharmacology
- Blood-Brain Barrier -- drug effects
- Brain -- drug effects
- Capillary Permeability -- drug effects
- Caspase 3 -- metabolism
- Disease Models, Animal
- Epilepsy -- drug therapy
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- pharmacology
- Male
- Nitric Oxide Synthase Type III -- antagonists & inhibitors
- Penicillin G
- RNA, Messenger -- metabolism
- Random Allocation
- Rats, Sprague-Dawley
- Rosuvastatin Calcium -- pharmacology
- Simvastatin -- pharmacology
- Tumor Suppressor Protein p53 -- metabolism
- bcl-2-Associated X Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.